Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Updated: December 31, 2022Bill #: 484Policy Area: CommerceCongress: 117Type: hres
View Document

Sponsors

Co-Sponsors

Register to Vote

Election Guides

Work at the Polls

Congress Members

Donate